Skip to main content

Warning notification:Warning

Unfortunately, you are using an outdated browser. Please, upgrade your browser to improve your experience with HSE. The list of supported browsers:

  1. Chrome
  2. Edge
  3. FireFox
  4. Opera
  5. Safari

Corporate Pharmaceutical Unit

The Corporate Pharmaceutical Unit is the interface between the HSE and the Pharmaceutical Industry in relation to medicine pricing and reimbursement applications and the operation of the national pricing framework agreements.

Corporate Pharmaceutical Unit,
HSE, Primary Care Reimbursement Service,
J5 Plaza, North Business Park, Exit 5, M50, North Road,
Finglas,
Dublin 11,
D11 PXT0.

Phone: 01 891 5725

CPU@hse.ie

2026 Closing Dates for Applications (PDF, 63 KB, 1 page)

Pricing and Reimbursement Application Instruction (PDF, 408 KB, 2 pages)

Forms

Price Application Form (PDF, 197 KB, 2 pages)

Product Withdrawal Form (PDF, 42 KB, 2 pages)

Marketing Authorisation or Commercial Responsibilities Transfer Form (PDF, 161 KB, 2 pages)

Rename Product Application Form (PDF, 151 KB, 2 pages)

IPHA and MFI Agreements 2026 - 2029

The Framework Agreement on the Supply and Pricing of Medicines (IPHA) (PDF, 390 KB, 40 pages)

The Framework Agreement on the Supply and Pricing of Medicines (MFI) (PDF, 391 KB, 47 pages)

Drugs Group Minutes

2026
2025
2024

Pricing and Reimbursement Application Tracker

Pricing and Reimbursement Application Tracker

IPHA and MFI Price Reductions

IPHA and MFI Price Reductions 2026 (Excel, 71 KB)

IPHA Price Reductions 2025 (Excel, 67 KB)

IPHA Price Reductions 2024 (Excel, 85 KB)

IPHA Price Reductions 2023 (Excel, 91 KB)